HYPERCOAGULABILITY IN OTOLOGIC PATIENTS

被引:11
作者
GOLD, S [1 ]
KAMERER, DB [1 ]
HIRSCH, BE [1 ]
CASS, SP [1 ]
机构
[1] UNIV PITTSBURGH,SCH MED,INST EYE & EAR,DEPT OTOLARYNGOL,SUITE 500,230 LOTHROP ST,PITTSBURGH,PA 15213
关键词
D O I
10.1016/0196-0709(93)90090-T
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Introduction: Three patients with otologic disorders developed complications related to hypercoagulability. This report was prepared to increase the awareness among otolaryngologists of the diagnosis and management of hypercoagulable states, and to encourage expert consultation when indicated. Materials and Methods: One patient with dural venous sinus thrombosis complicating an otitis media, one patient with a large glomus jugulare tumor, and one patient with a sudden sensorineural hearing loss were treated by the otolaryngology service. Suspicious thromboembolic events were evaluated by the hematology service, and appropriate anticoagulative therapy was recommended. Results: One patient with an inherited hypercoagulopathy and two patients with acquired hypercoagulopathies were treated for otologic problems. Two of the patients were stabilized and discharged on life-long anticoagulation therapy. The third patient, in spite of intensive medical and surgical support, eventually succumbed to complications to which an acquired hypercoagulable state made a significant contribution. Expert consultants made the hematologic diagnoses and treatment recommendations. Conclusion: Otolaryngologists should be aware that hypercoagulable states may now be more accurately diagnosed and characterized, and that thorough investigation of thromboembolic events may affect treatment decisions. © 1993.
引用
收藏
页码:327 / 331
页数:5
相关论文
共 9 条
[1]  
Bowen, Vukelja, Hypercoagulable states, Postgrad Med J, 91, pp. 117-132, (1992)
[2]  
Elias, Eldor, Thromboembolism in patients with the “lupus” type circulating anticoagulant, Arch Intern Med, 144, pp. 510-515, (1984)
[3]  
Love, Santoro, Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders, Ann Intern Med, 112, pp. 682-698, (1990)
[4]  
Howard, Firkin, Healy, Et al., Lupus anticoagulant in women with multiple spontaneous miscarriage, Am J Hematol, 26, pp. 175-178, (1987)
[5]  
DeWolf, Carreras, Moerman, Et al., Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant, Am J Obstet Gynecol, 142, pp. 829-834, (1982)
[6]  
Asherson, Harris, Anticardiolipin antibodies—Clinical associations, Postgrad Med J, 62, pp. 1081-1087, (1986)
[7]  
Lockshin, Antiphospholipid antibody syndrome, JAMA, 268, pp. 1451-1453, (1992)
[8]  
Coller, Owen, Jesty, Et al., Deficiency of plasma protein S, protein C, or antithrombin III and arterial thrombosis, Arteriosclerosis, 7, pp. 456-462, (1987)
[9]  
Kimura, Perlman, Arterial obstruction of the labyrinth. I. Cochlear changes, Ann Otol Rhinol Laryngol, 67, pp. 5-13, (1958)